VantAI appoints John Cuozzo as SVP, Head of Drug Discovery

VantAI, a leader in generative AI and drug discovery, today announced the appointment of John Cuozzo, PhD as SVP, Head of Drug Discovery. Cuozzo is an experienced scientific leader with a strong track record of building novel discovery platforms and leading successful drug discovery programs. He brings over 20 years...

The post VantAI appoints John Cuozzo as SVP, Head of Drug Discovery first appeared on AI-TechPark.

building discovery drug discovery generative head john leader machine learning novel phd platforms scientific